Matthew J. Ellis MD
Kidney & Pancreas Transplantation
Medical Director of Kidney & Pancreas Transplantation
Join to View Full Profile
40 Duke Medicine CirDurham, NC 27710
Phone+1 919-681-1400
Dr. Ellis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Nephrology, 2005 - 2007- Duke University HospitalResidency, Internal Medicine, 2003 - 2005
- Duke University HospitalInternship, Internal Medicine, 2002 - 2003
Duke University School of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2002 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
Clinical Trials
- Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer Start of enrollment: 2003 Jun 06
- Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer Start of enrollment: 2003 Oct 01
- Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSystem Interventions to Achieve Early and Equitable Kidney Transplants (STEPS): Protocol for STEPS, a randomized comparative effectiveness clinical trial.L Ebony Boulware, Patti L Ephraim, Tariq Shafi, Jamie A Green, Teri Browne
Contemporary Clinical Trials. 2025-06-01 - 1 citationsImproving deceased donor kidney utilization: predicting risk of nonuse with interpretable models.Ruoting Li, Sait Tunç, Osman Y Özaltın, Matthew J Ellis
Frontiers in Artificial Intelligence. 2025-01-01 - 5 citationsDe novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy.Olivia S Jew, Winston W Liu, Christopher Stamey, Meenal Kheterpal, Sarah A Myers
Journal of the American Academy of Dermatology. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
